Park Medi World Reports Significant Q4 Growth: Net Profit Rises 58% to ₹70.9 Crore, Revenue Increases 47%

Park Medi World Reports Strong Q4 FY26 Numbers

Park Medi World announced a robust set of financial results for the fourth quarter of fiscal year 2026 (Q4 FY26) on May 12, 2026. The company's consolidated net profit attributable to the owners of the company rose by 58% year-over-year (YoY) to ₹70.9 crore, compared to ₹44.8 crore in the same quarter last year.

The company's consolidated net profit after tax also increased by 47% YoY to ₹76.8 crore, compared to ₹52.4 crore in the same quarter last year. Revenue from operations grew by 30% YoY to ₹460.4 crore, up from ₹353.9 crore. At the operating level, Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) increased by 44% YoY to ₹127.4 crore, while margins expanded to 27.7% from 25.0%, indicating better cost efficiencies and operating leverage.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Park Medi World witnessed significant growth during the year, achieving a 20% boost in capacity by adding 610 beds. This was facilitated by acquisitions in Bhatinda (250 beds) and Agra (360 beds), bringing the total capacity to 3,610 beds as of March 31, 2026. Additionally, the company opened its largest greenfield hospital in Panchkula (350 beds) in April 2026, further raising the capacity to 3,960 beds. Furthermore, it finalised the acquisition of Febris Multi-Speciality Hospital (200 beds) in Narela, Delhi, which is anticipated to commence operations in Q2 FY27.

The company is enhancing its regional presence by obtaining approvals for a 150-bed expansion at its Mohali facility, bringing the total capacity there to 500 beds. Once completed, Park Medi World will become the largest private healthcare provider in the Tricity area with a total of 850 beds.

Park Medi World Share Price

Park Medi World's share price opened at ₹264.85 apiece on the BSE on May 12, 2026, touched an intraday high of ₹266.95 apiece, and an intraday low of ₹254 apiece. The company's share price has risen by over 6% in the past week and nearly 9% over two weeks, while extending its rally to over 21% in the last month. The uptrend becomes more pronounced over a slightly longer horizon, with the stock rising around 47% over three months and nearly 70% year to date, highlighting sharp outperformance.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Park Medi World made its stock market debut on December 17, 2025, listing on both the BSE and the NSE. The company remains focused on disciplined capital allocation, maintaining a strong balance sheet, and pursuing calibrated expansion. In the near term, its priorities include seamless integration of acquired assets, improving utilisation across new facilities, and sustaining profitability. Over the medium term, the company aims to selectively explore growth opportunities while continuing its commitment to delivering affordable, high-quality healthcare and creating long-term value for stakeholders.